9th Annual Biomarkers Congress 2014

  • Conference Call
  • Oxford Global Con­fer­ences Ltd are proud to present the 9th Annual Bio­mark­ers Con­gress 2014, tak­ing place on 25 & 26 Feb­ru­ary 2014 in Man­ches­ter, United King­dom.

    The increas­ing inter­est in bio­marker dis­cov­ery in recent years has pushed bio­marker research into the fore­ground of the mod­ern phar­ma­ceu­ti­cal indus­try. New iden­ti­fi­ca­tion tech­nolo­gies have both widened the scope of bio­marker research and under­lined the need for robust val­i­da­tion, improved pre­dic­tive value and the clear demon­stra­tion of clin­i­cal relevance.

    The Bio­mark­ers Con­gress will cover the lat­est advances in bio­marker dis­cov­ery and ver­i­fi­ca­tion, includ­ing mass cytom­e­try, selected reac­tion mon­i­tor­ing and chem­i­cal genetics.

    Our expert speak­ers will also dis­cuss efforts to increase bio­marker sen­si­tiv­ity and speci­ficity through genomic analy­sis, infor­mat­ics approaches and bet­ter sam­ple man­age­ment. In the Com­pan­ion Diag­nos­tics stream, pre­sen­ta­tions will cover emerg­ing tech­nolo­gies, opti­mi­sa­tion of exist­ing plat­forms and strate­gies to improve strate­gic partnerships.

    To build on the clin­i­cal case stud­ies shared at last year’s event, we are pleased to intro­duce the co-​located “Bio­mark­ers in Clin­i­cal Devel­op­ment Con­gress”, focus­ing on the role of bio­mark­ers in clin­i­cal deci­sion mak­ing, drug effi­cacy pre­dic­tion and clin­i­cal safety. Key deci­sion mak­ers in per­son­alised med­i­cine will com­ple­ment these dis­cus­sions with their insights into phar­ma­coge­nomics, strat­i­fi­ca­tion mark­ers and pre­ci­sion medicine.

    Con­gress Topics

    In keep­ing with Oxford Global’s highly suc­cess­ful life sci­ences series, an expert panel of over 50 speak­ers will present a full con­fer­ence pro­gramme cov­er­ing the top­ics out­lined below:

    Bio­mark­ers In Dis­cov­ery & Pre­clin­i­cal Development

    (Day 1 Stream 1)

    • Safety bio­mark­ers: val­i­da­tion and regulation
    • Bio­marker research: key learn­ings from pre­clin­i­cal mod­els and exper­i­men­tal medicine
    • PK/​PD stud­ies: pre­dic­tive sci­ence from a bio­marker perspective
    • Imag­ing bio­mark­ers: new technologies
    • Bio­marker out­sourc­ing strategies
    • Cap­tur­ing real-​world data in bio­marker research

    Com­pan­ion Diagnostics

    (Day 1 Stream 2)

    • How best to mature emerg­ing tech­nolo­gies into com­pan­ion diagnostics
    • Com­pan­ion diag­nos­tics in can­cer drug development
    • Human tis­sue col­lec­tion in diag­nos­tics research
    • Strate­gic part­ner­ship best prac­tice in com­pan­ion diag­nos­tics development
    • Opti­mis­ing tar­gets and plat­forms for the devel­op­ment of bio­med­ical diagnostics

    Bio­marker Dis­cov­ery & Verification

    (Day 2 Stream 1)

    • Bio­marker analy­sis: tech­nolo­gies & platforms
    • Devel­op­ment and val­i­da­tion of chal­leng­ing bio­marker assays
    • Appli­ca­tions of selected reac­tion mon­i­tor­ing in pharma
    • Infor­mat­ics in bio­marker discovery
    • Mass cytom­e­try: a promis­ing novel tech­nol­ogy for bio­marker discovery
    • Big data inno­va­tion in bio­marker research
    • The role of biobank­ing in bio­marker research

    Inno­va­tions In Bio­marker Research

    (Day 2 Stream 2)

    • Col­lab­o­ra­tive strate­gies: build­ing on the suc­cess of safety bio­marker initiatives
    • Lat­est updates from cor­rel­a­tive sci­ence teams
    • New advances in cir­cu­la­tion tumour cell research
    • Novel bio­marker iden­ti­fi­ca­tion meth­ods: exploit­ing struc­ture and chem­i­cal genetics
    • Inno­va­tion case stud­ies: oncol­ogy and res­pi­ra­tory biomarkers

    Bio­mark­ers In Clin­i­cal Devel­op­ment Congress

    Clin­i­cal Biomarkers

    (Day 1)

    • Bio­marker devel­op­ment and clin­i­cal application
    • Bio­marker research: a clinician’s perspective
    • Trans­lat­ing bio­mark­ers into clin­i­cal assays
    • Clin­i­cal genet­ics: devel­op­ing diag­nos­tic assays with clin­i­cal utility
    • Fit for pur­pose devel­op­ment of clin­i­cal biomarkers
    • Suc­cess­ful clin­i­cal val­i­da­tion of biomarkers

    Clin­i­cal Tri­als & Per­son­alised Medicine

    (Day 2)

    • Advanc­ing per­son­alised med­i­cine: case stud­ies from clin­i­cal teams
    • Per­son­alised med­i­cine and phar­ma­coge­nomics: the generic company’s perspective
    • Find­ing the right patient pop­u­la­tion: min­ing clin­i­cal study data
    • Pre­ci­sion med­i­cine: updates from large pharma
    • Devel­op­ing patient selec­tion markers
    • Iden­ti­fy­ing the right patient for tar­geted therapy

    Who will attend

    The 9th Annual Bio­mark­ers Con­gress is an exclu­sive event designed for senior level atten­dees from lead­ing phar­ma­ceu­ti­cal, bio­phar­ma­ceu­ti­cal, biotech­nol­ogy, diag­nos­tics, CRO and solu­tion provider com­pa­nies, along with highly esteemed mem­bers of aca­d­e­mic and gov­ern­ment institutions.

    Del­e­gates typ­i­cally include VPs, Direc­tors and Global Heads of:

    • Adap­tive trial design
    • Assay devel­op­ment
    • Assay val­i­da­tion
    • Biobank­ing
    • Bioin­for­mat­ics
    • Bio­marker development
    • Bio­marker identification
    • Bio­marker validation
    • Bio­marker discovery
    • Clin­i­cal safety
    • Com­pan­ion diagnostics
    • Immunoas­says
    • Patient strat­i­fi­ca­tion
    • Per­son­alised medicine
    • Phar­ma­coge­nomics
    • PK/​PD
    • Pre­ci­sion medicine
    • Rx/​Dx co-​development

    Sub­mit a Poster

    For atten­dees inter­ested in sub­mit­ting a poster, there are oppor­tu­ni­ties now avail­able. Your poster pre­sen­ta­tion will be located in the exhi­bi­tion room for two days along­side other posters from senior sci­en­tists work­ing in indus­try and academia.

    We will require:

    • Poster title, Abstract (200 words or less)
    • Prin­ci­pal author, Organ­i­sa­tion, Mail­ing address, Email, Tele­phone, Fax
    • Addi­tional authors

    In order to secure your board space a fee of £125 will be required.

    To take advan­tage of this oppor­tu­nity you need to be reg­is­tered as a paid del­e­gate over the 2 days. We have lim­ited spaces avail­able, so please reg­is­ter soon!

    Advi­sory Board

    Our 2014 Advi­sory Board includes

    • Corinne Solier – Group Head, Clin­i­cal Pro­tein Bio­mark­ers, Roche
    • Terry Robins – Direc­tor, Bio­marker Research and Devel­op­ment & Global Sci­en­tific Affairs, Quest Diagnostics
    • John Allinson – VP Bio­marker Lab Ser­vices, Icon
    • Khusru Asadul­lah – VP and Head of Global Bio­marker, Bayer Health Care
    • Stephen Roy Pen­ning­ton – Pro­fes­sor of Pro­teomics, Uni­ver­sity Col­lege Dublin
    • Alain Van Gool, Pro­fes­sor – Senior Sci­en­tist Inte­gra­tor Meta­bolic Health Research, TNO
    starting: ending: 26.02.2014 Location: , Category:

    Timeline

    Conference START 26.02.2014 END

    All deadlines have expired!

    This conference has no more open deadlines. There may be successive conferences coming up you may by interested in.

    Please check our conference list and search...

    Conference Facts

    Location , Address Old Trafford, Sir Matt Busby Way Category Organiser More Info Conference Website

    Further interesting Conferences

    Currently we have no similar events listed. Please check our website regulary, subscribe to our RSS-Feed or follow us on twitter for new listings.